Terms: = Sarcomas AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS
8 results:
1. Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma.
Leng D; Yang Z; Sun H; Song C; Huang C; Ip KU; Chen G; Deng CX; Zhang XD; Zhao Q
Clin Cancer Res; 2023 Oct; 29(19):3986-4001. PubMed ID: 37527025
[TBL] [Abstract] [Full Text] [Related]
2. Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas.
Jaeger HK; Davis DA; Nair A; Shrestha P; Stream A; Yaparla A; Yarchoan R
Sci Rep; 2023 Jul; 13(1):11596. PubMed ID: 37463943
[TBL] [Abstract] [Full Text] [Related]
3. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
4. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
Eckardt JN; Stölzel F; Kunadt D; Röllig C; Stasik S; Wagenführ L; Jöhrens K; Kuithan F; Krämer A; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Kroschinsky F; Berdel WE; Ehninger G; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Bornhäuser M; Thiede C; Middeke JM
J Hematol Oncol; 2022 May; 15(1):60. PubMed ID: 35562747
[TBL] [Abstract] [Full Text] [Related]
5. Neem leaf glycoprotein reverses tumor-induced and age-associated thymic involution to maintain peripheral CD8
Guha I; Bhuniya A; Nandi P; Dasgupta S; Sarkar A; Saha A; Das J; Ganguly N; Ghosh S; Ghosh T; Sarkar M; Ghosh S; Majumdar S; Baral R; Bose A
Immunotherapy; 2020 Aug; 12(11):799-818. PubMed ID: 32698648
[No Abstract] [Full Text] [Related]
6. Tumor Arrests DN2 to DN3 Pro T Cell Transition and Promotes Its Conversion to Thymic Dendritic Cells by Reciprocally Regulating Notch1 and ikaros Signaling.
Guha I; Bhuniya A; Shukla D; Patidar A; Nandi P; Saha A; Dasgupta S; Ganguly N; Ghosh S; Nair A; Majumdar S; Saha B; Storkus WJ; Baral R; Bose A
Front Immunol; 2020; 11():898. PubMed ID: 32582141
[TBL] [Abstract] [Full Text] [Related]
7. Immunomodulatory drugs target ikzf1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract] [Full Text] [Related]
8. Dominant-negative ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.
Theocharides AP; Dobson SM; Laurenti E; Notta F; Voisin V; Cheng PY; Yuan JS; Guidos CJ; Minden MD; Mullighan CG; Torlakovic E; Dick JE
Leukemia; 2015 Jan; 29(1):177-87. PubMed ID: 24791856
[TBL] [Abstract] [Full Text] [Related]
